Market Updates

Unigen Pharmaceuticals Collaborates to Develop Novel Skin Lightening Ingredient

Unigen Pharmaceuticals, Inc., Lacey, WA, has formed a research and development collaboration with Professor David Minter in the Department of Chemistry at Texas Christian University (TCU) for the development of a novel skin-lightening product derived from a medicinal plant. The mechanism of action of this skin-lightening product is based on the inhibition of tyrosinase, an enzyme responsible for the production of melanin, the skin’s natural pigment.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters